Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | C1orf63 |
| Upstream (Parents) |
|---|
| (<<) SFPQ → C1orf63 |
| (<<) RUFY3 → C1orf63 |
| (<<) SECISBP2L → C1orf63 |
| (<<) GOLGA8IP → C1orf63 |
| (<<) CLK1 → C1orf63 |
| Downstream (Children) |
|---|
| C1orf63 → PHEX (>>) |
| C1orf63 → SFPQ (>>) |
| C1orf63 → MPO (>>) |
| C1orf63 → LIG3 (>>) |
| C1orf63 → KIAA0528 (>>) |
| C1orf63 → HIST1H1D (>>) |
| C1orf63 → DNAJB14 (>>) |
| C1orf63 → NACA2///NACAP1///NACA (>>) |
| C1orf63 → CPT1B///CHKB (>>) |
| C1orf63 → LOC652637///WHAMML1 (>>) |
| C1orf63 → METTL3 (>>) |
| C1orf63 → TAF13 (>>) |
| C1orf63 → AASS (>>) |
| C1orf63 → AMY2B///AMY2A///AMY1C///AMY1B///AMY1A (>>) |
| C1orf63 → FLJ13197 (>>) |
| C1orf63 → MYOZ2 (>>) |
| C1orf63 → DOPEY1 (>>) |
| C1orf63 → C6orf54 (>>) |
| C1orf63 → RUFY3 (>>) |
| C1orf63 → LYPD1 (>>) |
| C1orf63 → UMPS (>>) |
| C1orf63 → SECISBP2L (>>) |
| C1orf63 → MST1 (>>) |
| C1orf63 → LOC728636///LOC643696///GOLGA6L9///GOLGA6L5 (>>) |
| C1orf63 → POU5F1P4 (>>) |
| C1orf63 → HNRNPD (>>) |
| C1orf63 → KCTD7 (>>) |
| C1orf63 → ME3 (>>) |
| C1orf63 → GOLGA8IP (>>) |
| C1orf63 → CSAD (>>) |
| C1orf63 → HNRNPA1 (>>) |
| C1orf63 → MAN2A2 (>>) |
| C1orf63 → MAP3K8 (>>) |
| C1orf63 → RRP9 (>>) |
| C1orf63 → RPP25 (>>) |
| C1orf63 → SCRN1 (>>) |
| C1orf63 → CLK1 (>>) |
| C1orf63 → MCM2 (>>) |
| C1orf63 → XIST (>>) |
| C1orf63 → HDAC5 (>>) |
| C1orf63 → ARGLU1 (>>) |
